3349 — Cosmos Pharmaceutical Cashflow Statement
0.000.00%
Last trade - 00:00- ¥711bn
- ¥717bn
- ¥965bn
- 83
- 28
- 99
- 83
Annual cashflow statement for Cosmos Pharmaceutical, fiscal year end - May 31st, JPY millions except per share, conversion factor applied.
2020 May 31st | 2021 May 31st | 2022 May 31st | 2023 May 31st | 2024 May 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | Yuho | Yuho | Yuho | Yuho | Yuho |
| Standards: | — | — | JAS | JAS | JAS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 30,402 | 38,596 | 33,048 | 32,773 | 33,719 |
| Depreciation | |||||
| Non-Cash Items | 1,162 | -2,758 | -187 | 315 | 636 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 20,335 | -21,750 | -15,777 | 3,978 | 896 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Accounts Payable | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 65,461 | 27,873 | 32,194 | 54,434 | 55,175 |
| Capital Expenditures | -25,948 | -26,064 | -43,497 | -46,636 | -55,810 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | -1,008 | 6,683 | -220 | -2,477 | -1,519 |
| Sale of Fixed Assets | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -26,956 | -19,381 | -43,717 | -49,113 | -57,329 |
| Financing Cash Flow Items | -2 | -2 | -2 | -3 | -1 |
| Other Financing Cash Flow | |||||
| Total Cash Dividends Paid | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -5,405 | -5,507 | -6,222 | 3,245 | 8,527 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 33,100 | 2,985 | -17,745 | 8,566 | 6,373 |